BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nolan JP. The role of intestinal endotoxin in liver injury: A long and evolving history. Hepatology 2010;52:1829-35. [DOI: 10.1002/hep.23917] [Cited by in Crossref: 152] [Cited by in F6Publishing: 147] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Hatton G, Shawcross DL. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis? Expert Review of Gastroenterology & Hepatology 2018;13:1-2. [DOI: 10.1080/17474124.2019.1543587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Muriel P, Ramos-tovar E, Montes-páez G, Buendía-montaño L. Experimental Models of Liver Damage Mediated by Oxidative Stress. Liver Pathophysiology. Elsevier; 2017. pp. 529-46. [DOI: 10.1016/b978-0-12-804274-8.00040-0] [Cited by in Crossref: 12] [Article Influence: 2.4] [Reference Citation Analysis]
3 Zheng XF, Hu XY, Ma B, Fang H, Zhang F, Mao YF, Yang FY, Xiao SC, Xia ZF. Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells. Front Pharmacol. 2018;9:959. [PMID: 30197594 DOI: 10.3389/fphar.2018.00959] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
4 Stine JG, Northup PG. Coagulopathy Before and After Liver Transplantation: From the Hepatic to the Systemic Circulatory Systems. Clin Liver Dis 2017;21:253-74. [PMID: 28364812 DOI: 10.1016/j.cld.2016.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
5 Wang X, Zhang L, Wei Z, Zhang X, Gao Q, Ma Y, Liu X, Jiang Y, Liu X, Guo C, Wang X. The inhibitory action of PDCD4 in lipopolysaccharide/D-galactosamine-induced acute liver injury. Lab Invest 2013;93:291-302. [PMID: 23295647 DOI: 10.1038/labinvest.2012.174] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
6 Kulhankova K, Kinney KJ, Stach JM, Gourronc FA, Grumbach IM, Klingelhutz AJ, Salgado-Pabón W. The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function. Infect Immun 2018;86:e00848-17. [PMID: 29229737 DOI: 10.1128/IAI.00848-17] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
7 Steib CJ, Gmelin L, Pfeiler S, Schewe J, Brand S, Göke B, Gerbes AL. Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension. Life Sci 2013;93:543-51. [PMID: 24007798 DOI: 10.1016/j.lfs.2013.08.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
8 Grant CJ, Huang SS, McIntyre CW. Hepato-splanchnic circulatory stress: An important effect of hemodialysis. Semin Dial 2019;32:237-42. [PMID: 30937954 DOI: 10.1111/sdi.12782] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Tomar S, Zumbrun EE, Nagarkatti M, Nagarkatti PS. Protective role of cannabinoid receptor 2 activation in galactosamine/lipopolysaccharide-induced acute liver failure through regulation of macrophage polarization and microRNAs. J Pharmacol Exp Ther 2015;353:369-79. [PMID: 25749929 DOI: 10.1124/jpet.114.220368] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
10 Saltzman ET, Palacios T, Thomsen M, Vitetta L. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Front Microbiol 2018;9:61. [PMID: 29441049 DOI: 10.3389/fmicb.2018.00061] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 16.0] [Reference Citation Analysis]
11 Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, Tacke F. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One. 2011;6:e21381. [PMID: 21731723 DOI: 10.1371/journal.pone.0021381] [Cited by in Crossref: 153] [Cited by in F6Publishing: 139] [Article Influence: 13.9] [Reference Citation Analysis]
12 Ambade A, Catalano D, Lim A, Mandrekar P. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice. Hepatology. 2012;55:1585-1595. [PMID: 22105779 DOI: 10.1002/hep.24802] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
13 Ingawale DK, Mandlik SK, Naik SR. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environ Toxicol Pharmacol. 2014;37:118-133. [PMID: 24322620 DOI: 10.1016/j.etap.2013.08.015] [Cited by in Crossref: 99] [Cited by in F6Publishing: 89] [Article Influence: 11.0] [Reference Citation Analysis]
14 Qian H, Deng X, Huang ZW, Wei J, Ding CH, Feng RX, Zeng X, Chen YX, Ding J, Qiu L, Hu ZL, Zhang X, Wang HY, Zhang JP, Xie WF. An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells. Cell Res 2015;25:930-45. [PMID: 26169608 DOI: 10.1038/cr.2015.84] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
15 Yuan LY, Wu YY, Li H. Microbial modulators for treatment of liver failure with endotoxemia: Research progress. Shijie Huaren Xiaohua Zazhi 2013; 21(14): 1286-1291 [DOI: 10.11569/wcjd.v21.i14.1286] [Reference Citation Analysis]
16 Zhang T, Li J, Liu CP, Guo M, Gao CL, Zhou LP, Long Y, Xu Y. Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis. Ann Transl Med 2021;9:873. [PMID: 34164507 DOI: 10.21037/atm-21-2158] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Lemesch S, Ribitsch W, Schilcher G, Spindelböck W, Hafner-Gießauf H, Marsche G, Pasterk L, Payerl D, Schmerböck B, Tawdrous M, Rosenkranz AR, Stiegler P, Kager G, Hallström S, Oettl K, Eberhard K, Horvath A, Leber B, Stadlbauer V. Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease. Sci Rep 2016;6:34534. [PMID: 27698480 DOI: 10.1038/srep34534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
18 Hasan RA, Koh AY, Zia A. The gut microbiome and thromboembolism. Thromb Res 2020;189:77-87. [PMID: 32192995 DOI: 10.1016/j.thromres.2020.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Sayadi A, Nguyen A, Bard FA, Bard-chapeau EA. Zip14 expression induced by lipopolysaccharides in macrophages attenuates inflammatory response. Inflamm Res 2013;62:133-43. [DOI: 10.1007/s00011-012-0559-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
20 Takaya H, Yoshiji H, Kawaratani H, Sakai K, Matsumoto M, Fujimura Y, Fukui H. Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure. Biomed Rep 2017;7:277-85. [PMID: 28894574 DOI: 10.3892/br.2017.945] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
21 Wang GH, Lu J, Ma KL, Zhang Y, Hu ZB, Chen PP, Lu CC, Zhang XL, Liu BC. The Release of Monocyte-Derived Tissue Factor-Positive Microparticles Contributes to a Hypercoagulable State in Idiopathic Membranous Nephropathy. J Atheroscler Thromb 2019;26:538-46. [PMID: 30429407 DOI: 10.5551/jat.46284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kong Y, Yan T, Tong Y, Deng H, Tan C, Wan M, Wang M, Meng X, Wang Y. Gut Microbiota Modulation by Polyphenols from Aronia melanocarpa of LPS-Induced Liver Diseases in Rats. J Agric Food Chem 2021;69:3312-25. [PMID: 33688735 DOI: 10.1021/acs.jafc.0c06815] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Xiao T, Cui Y, Ji H, Yan L, Pei D, Qu S. Baicalein attenuates acute liver injury by blocking NLRP3 inflammasome. Biochem Biophys Res Commun 2021;534:212-8. [PMID: 33272570 DOI: 10.1016/j.bbrc.2020.11.109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Ommati MM, Farshad O, Niknahad H, Mousavi K, Moein M, Azarpira N, Mohammadi H, Jamshidzadeh A, Heidari R. Oral administration of thiol-reducing agents mitigates gut barrier disintegrity and bacterial lipopolysaccharide translocation in a rat model of biliary obstruction. Current Research in Pharmacology and Drug Discovery 2020;1:10-8. [DOI: 10.1016/j.crphar.2020.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
25 Carnevale R, Raparelli V, Nocella C, Bartimoccia S, Novo M, Severino A, De Falco E, Cammisotto V, Pasquale C, Crescioli C, Scavalli AS, Riggio O, Basili S, Violi F. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. J Hepatol. 2017;67:950-956. [PMID: 28716745 DOI: 10.1016/j.jhep.2017.07.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
26 Sharma M, Mitnala S, Vishnubhotla RK, Mukherjee R, Reddy DN, Rao PN. The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. J Clin Exp Hepatol. 2015;5:147-158. [PMID: 26155043 DOI: 10.1016/j.jceh.2015.02.002] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 10.0] [Reference Citation Analysis]
27 Han C, Wei Y, Wang X, Cui Y, Bao Y, Shi W. Salvia miltiorrhiza polysaccharides protect against lipopolysaccharide-induced liver injury by regulating NF-κb and Nrf2 pathway in mice. Food and Agricultural Immunology 2019;30:979-94. [DOI: 10.1080/09540105.2019.1652250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Liu A, Shen Y, Du Y, Chen J, Pei F, Fu W, Qiao J. Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice. Microbial Pathogenesis 2018;125:418-22. [DOI: 10.1016/j.micpath.2018.10.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
29 Atif M, Warner S, Oo YH. Linking the gut and liver: crosstalk between regulatory T cells and mucosa-associated invariant T cells. Hepatol Int 2018;12:305-14. [PMID: 30027532 DOI: 10.1007/s12072-018-9882-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
30 Massey VL, Arteel GE. Acute alcohol-induced liver injury. Front Physiol 2012;3:193. [PMID: 22701432 DOI: 10.3389/fphys.2012.00193] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
31 Tang F, Fan K, Wang K, Bian C. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways. Biomed Pharmacother 2019;111:527-36. [PMID: 30597306 DOI: 10.1016/j.biopha.2018.12.096] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
32 Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:271-88. [PMID: 33150145 DOI: 10.2147/JHC.S277870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
33 Kwong EK, Zhou H. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases. Liver Res 2019;3:19-24. [PMID: 31360579 DOI: 10.1016/j.livres.2019.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
34 Wereszczynka-Siemiatkowska U, Swidnicka-Siergiejko A, Siemiatkowski A, Bondyra Z, Wasielica-Berger J, Mroczko B, Janica J, Dabrowski A. Endothelin 1 and transforming growth factor-β1 correlate with liver function and portal pressure in cirrhotic patients. Cytokine 2015;76:144-51. [PMID: 26144293 DOI: 10.1016/j.cyto.2015.05.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
35 Zeng X, Tang XJ, Sheng X, Ni W, Xin HG, Chen WZ, Jiang CF, Lin Y, Shi J, Shi B, Chen YX, Yuan ZL, Xie WF. Does low-dose rifaximin ameliorate endotoxemia in patients with liver cirrhosis: a prospective study. J Dig Dis 2015;16:665-74. [PMID: 26474237 DOI: 10.1111/1751-2980.12294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
36 Galbois A, Thabut D, Moreau R, Lebrec D. Neutralization of lipopolysaccharide effects in liver diseases, the quest for the holy grail. Hepatology 2011;54:376-376. [DOI: 10.1002/hep.24186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Yang F, Cai H, Zhang X, Sun J, Feng X, Yuan H, Zhang X, Xiao B, Li Q. An active marine halophenol derivative attenuates lipopolysaccharide-induced acute liver injury in mice by improving M2 macrophage-mediated therapy. Int Immunopharmacol 2021;96:107676. [PMID: 34023550 DOI: 10.1016/j.intimp.2021.107676] [Reference Citation Analysis]
38 Shin JW, Wang JH, Park HJ, Choi MK, Kim HG, Son CG. Herbal formula CGX ameliorates LPS/d-galactosamine-induced hepatitis. Food and Chemical Toxicology 2011;49:1329-34. [DOI: 10.1016/j.fct.2011.03.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
39 Vitetta L, Gobe G. Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics. Mol Nutr Food Res 2013;57:824-32. [PMID: 23450842 DOI: 10.1002/mnfr.201200714] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
40 Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3:279-288. [PMID: 22572877 DOI: 10.4161/gmic.19625] [Cited by in Crossref: 431] [Cited by in F6Publishing: 384] [Article Influence: 43.1] [Reference Citation Analysis]
41 Wang HJ, Gao B, Zakhari S, Nagy LE. Inflammation in alcoholic liver disease. Annu Rev Nutr. 2012;32:343-368. [PMID: 22524187 DOI: 10.1146/annurev-nutr-072610-145138] [Cited by in Crossref: 174] [Cited by in F6Publishing: 166] [Article Influence: 17.4] [Reference Citation Analysis]
42 Xie F, Dong J, Zhu Y, Wang K, Liu X, Chen D, Meng Q. HIF1a Inhibitor Rescues Acute-on-Chronic Liver Failure. Ann Hepatol 2019;18:757-64. [PMID: 31402229 DOI: 10.1016/j.aohep.2019.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lu SC. Dysregulation of glutathione synthesis in liver disease. Liver Research 2020;4:64-73. [DOI: 10.1016/j.livres.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
44 Kirpich IA, McClain CJ, Vatsalya V, Schwandt M, Phillips M, Falkner KC, Zhang L, Harwell C, George DT, Umhau JC. Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program. Alcohol Clin Exp Res 2017;41:747-57. [PMID: 28166367 DOI: 10.1111/acer.13346] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
45 Kumar M, Leon Coria A, Cornick S, Petri B, Mayengbam S, Jijon HB, Moreau F, Shearer J, Chadee K. Increased intestinal permeability exacerbates sepsis through reduced hepatic SCD-1 activity and dysregulated iron recycling. Nat Commun 2020;11:483. [PMID: 31980623 DOI: 10.1038/s41467-019-14182-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
46 Edwards L, Wanless IR. Mechanisms of liver involvement in systemic disease. Best Pract Res Clin Gastroenterol 2013;27:471-83. [PMID: 24090936 DOI: 10.1016/j.bpg.2013.08.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
47 Chen Y, Ouyang X, Hoque R, Garcia-Martinez I, Yousaf MN, Tonack S, Offermanns S, Dubuquoy L, Louvet A, Mathurin P, Massey V, Schnabl B, Bataller RA, Mehal WZ. β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway. J Hepatol 2018;69:687-96. [PMID: 29705237 DOI: 10.1016/j.jhep.2018.04.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
48 MacParland SA, Ma XZ, Chen L, Khattar R, Cherepanov V, Selzner M, Feld JJ, Selzner N, McGilvray ID. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression. J Virol 2016;90:5549-60. [PMID: 27009955 DOI: 10.1128/JVI.02557-15] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
49 Zhou Q, Jiang L, Qiu J, Pan Y, Swanda RV, Shi P, Li A, Zhang X. Oral Exposure to 1,4-Dioxane Induces Hepatic Inflammation in Mice: The Potential Promoting Effect of the Gut Microbiome. Environ Sci Technol 2020;54:10149-58. [DOI: 10.1021/acs.est.0c01543] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Li Y, Wang X, Wei Z, Mao H, Gao M, Liu Y, Ma Y, Liu X, Guo C, Zhang L, Wang X. Pretreatment with wortmannin alleviates lipopolysaccharide/d-galactosamine-induced acute liver injury. Biochemical and Biophysical Research Communications 2014;455:234-40. [DOI: 10.1016/j.bbrc.2014.10.152] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
51 Dong L, Han X, Tao X, Xu L, Xu Y, Fang L, Yin L, Qi Y, Li H, Peng J. Protection by the Total Flavonoids from Rosa laevigata Michx Fruit against Lipopolysaccharide-Induced Liver Injury in Mice via Modulation of FXR Signaling. Foods 2018;7:E88. [PMID: 29890650 DOI: 10.3390/foods7060088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
52 Jang JY, Kim TY, Sohn JH, Lee TH, Jeong SW, Park EJ, Lee SH, Kim SG, Kim YS, Kim HS, Kim BS. Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortality. Aliment Pharmacol Ther 2014;40:819-26. [DOI: 10.1111/apt.12891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
53 Thapa M, Chinnadurai R, Velazquez VM, Tedesco D, Elrod E, Han JH, Sharma P, Ibegbu C, Gewirtz A, Anania F, Pulendran B, Suthar MS, Grakoui A. Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity. Hepatology 2015;61:2067-79. [PMID: 25711908 DOI: 10.1002/hep.27761] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
54 Vitetta L, Henson JD. Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease. Hepatobiliary Surg Nutr 2020;9:526-9. [PMID: 32832510 DOI: 10.21037/hbsn.2019.11.24] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Woodhouse CA, Patel VC, Goldenberg S, Sanchez-Fueyo A, China L, O'Brien A, Flach C, Douiri A, Shawcross D. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial. BMJ Open 2019;9:e023518. [PMID: 30772848 DOI: 10.1136/bmjopen-2018-023518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
56 Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014; 20(42): 15499-15517 [PMID: 25400435 DOI: 10.3748/wjg.v20.i42.15499] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
57 Huebener P, Schwabe RF. Regulation of wound healing and organ fibrosis by toll-like receptors. Biochim Biophys Acta. 2013;1832:1005-1017. [PMID: 23220258 DOI: 10.1016/j.bbadis.2012.11.017] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
58 Tsai JH, Ferrell LD, Tan V, Yeh MM, Sarkar M, Gill RM. Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition. Mod Pathol 2017;30:834-42. [PMID: 28256569 DOI: 10.1038/modpathol.2017.13] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
59 Liu MW, Liu R, Wu HY, Zhang W, Xia J, Dong MN, Yu W, Wang Q, Xie FM, Wang R, Huang YQ, Qian CY. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression. Int J Mol Med 2016;38:1419-32. [PMID: 27666960 DOI: 10.3892/ijmm.2016.2749] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
60 Meroni M, Longo M, Dongiovanni P. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients. 2019;11. [PMID: 31689910 DOI: 10.3390/nu11112642] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
61 王宪波, 高方媛. 慢加急性肝衰竭: 东西方诊断和预后的差异. 世界华人消化杂志 2017; 25(21): 1910-1920 [DOI: 10.11569/wcjd.v25.i21.1910] [Reference Citation Analysis]
62 Violi F, Lip GY, Cangemi R. Endotoxemia as a trigger of thrombosis in cirrhosis. Haematologica. 2016;101:e162-e163. [PMID: 27033239 DOI: 10.3324/haematol.2015.139972] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
63 Teschke R, Uetrecht J. Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues. Ann Transl Med 2021;9:730. [PMID: 33987428 DOI: 10.21037/atm-2020-ubih-05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J Parenter Enteral Nutr. 2011;35:14S-20S. [PMID: 21807932 DOI: 10.1177/0148607111413772] [Cited by in Crossref: 182] [Cited by in F6Publishing: 169] [Article Influence: 16.5] [Reference Citation Analysis]
65 Hao L, Sun Q, Zhong W, Zhang W, Sun X, Zhou Z. Mitochondria-targeted ubiquinone (MitoQ) enhances acetaldehyde clearance by reversing alcohol-induced posttranslational modification of aldehyde dehydrogenase 2: A molecular mechanism of protection against alcoholic liver disease. Redox Biol 2018;14:626-36. [PMID: 29156373 DOI: 10.1016/j.redox.2017.11.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
66 Harm S, Gabor F, Hartmann J. Low-dose polymyxin: an option for therapy of Gram-negative sepsis. Innate Immun 2016;22:274-83. [PMID: 26993088 DOI: 10.1177/1753425916639120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
67 Romeiro FG, Augusti L. Nutritional assessment in cirrhotic patients with hepatic encephalopathy. World J Hepatol 2015; 7(30): 2940-2954 [PMID: 26730273 DOI: 10.4254/wjh.v7.i30.2940] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
68 El Shaffei I, Abdel-Latif GA, Farag DB, Schaalan M, Salama RM. Ameliorative effect of betanin on experimental cisplatin-induced liver injury; the novel impact of miRNA-34a on the SIRT1/PGC-1α signaling pathway. J Biochem Mol Toxicol 2021;35:1-14. [PMID: 33661552 DOI: 10.1002/jbt.22753] [Reference Citation Analysis]
69 . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
70 Szabo G, Petrasek J. Gut-liver axis and sterile signals in the development of alcoholic liver disease. Alcohol Alcohol 2017;52:414-24. [PMID: 28482064 DOI: 10.1093/alcalc/agx025] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
71 Liang X, Li T, Zhou Q, Pi S, Li Y, Chen X, Weng Z, Li H, Zhao Y, Wang H, Chen Y. Mesenchymal stem cells attenuate sepsis-induced liver injury via inhibiting M1 polarization of Kupffer cells. Mol Cell Biochem. 2019;452:187-197. [PMID: 30178273 DOI: 10.1007/s11010-018-3424-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
72 Darnaud M, Faivre J, Moniaux N. Targeting gut flora to prevent progression of hepatocellular carcinoma. J Hepatol. 2013;58:385-387. [PMID: 22940407 DOI: 10.1016/j.jhep.2012.08.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
73 Jia YN, Lu HP, Peng YL, Zhang BS, Gong XB, Su J, Zhou Y, Pan MH, Xu L. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Int Immunopharmacol 2018;56:105-12. [PMID: 29414639 DOI: 10.1016/j.intimp.2018.01.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
74 Woodhouse CA, Patel VC, Singanayagam A, Shawcross DL. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease. Aliment Pharmacol Ther. 2018;47:192-202. [PMID: 29083037 DOI: 10.1111/apt.14397] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
75 Tomar S, Nagarkatti M, Nagarkatti PS. 3,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling. Br J Pharmacol 2015;172:2133-47. [PMID: 25521277 DOI: 10.1111/bph.13036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
76 Center SA, Randolph JF, Warner KL, McDonough SP, Lucy JM, Sapa KC. Bacterial culture and immunohistochemical detection of bacteria and endotoxin in cats with suppurative cholangitis-cholangiohepatitis syndrome. J Am Vet Med Assoc 2021;:1-18. [PMID: 34936576 DOI: 10.2460/javma.20.10.0552] [Reference Citation Analysis]
77 Santos LA, Romeiro FG. Diagnosis and Management of Cirrhosis-Related Osteoporosis. Biomed Res Int. 2016;2016:1423462. [PMID: 27840821 DOI: 10.1155/2016/1423462] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
78 Yang Y, Bai T, Yao Y, Zhang D, Wu Y, Lian L, Nan J. Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury. Toxicology Letters 2016;262:80-91. [DOI: 10.1016/j.toxlet.2016.09.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
79 Xu R, Aruhan, Xiu L, Sheng S, Liang Y, Zhang H, Liu Y, Tong H, Du R, Wang X. Exopolysaccharides from Lactobacillus buchneri TCP016 Attenuate LPS- and d-GalN-Induced Liver Injury by Modulating the Gut Microbiota. J Agric Food Chem 2019;67:11627-37. [PMID: 31553177 DOI: 10.1021/acs.jafc.9b04323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
80 Lekić N, Canová NK, Hořínek A, Farghali H. The involvement of heme oxygenase 1 but not nitric oxide synthase 2 in a hepatoprotective action of quercetin in lipopolysaccharide-induced hepatotoxicity of D-galactosamine sensitized rats. Fitoterapia 2013;87:20-6. [PMID: 23537890 DOI: 10.1016/j.fitote.2013.03.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
81 Huang C, Wang J, Chen Z, Wang Y, Zhang W. 2-phenylethynesulfonamide Prevents Induction of Pro-inflammatory Factors and Attenuates LPS-induced Liver Injury by Targeting NHE1-Hsp70 Complex in Mice. PLoS One 2013;8:e67582. [PMID: 23805318 DOI: 10.1371/journal.pone.0067582] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
82 Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol. 2012;12:215-225. [PMID: 22362354 DOI: 10.1038/nri3167] [Cited by in Crossref: 179] [Cited by in F6Publishing: 165] [Article Influence: 17.9] [Reference Citation Analysis]
83 Zhan Y, Wang Z, Yang P, Wang T, Xia L, Zhou M, Wang Y, Wang S, Hua Z, Zhang J. Adenosine 5'-monophosphate ameliorates D-galactosamine/lipopolysaccharide-induced liver injury through an adenosine receptor-independent mechanism in mice. Cell Death Dis 2014;5:e985. [PMID: 24407238 DOI: 10.1038/cddis.2013.516] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
84 Yao L, Chen W, Song K, Han C, Gandhi CR, Lim K, Wu T. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury. PLoS One 2017;12:e0176106. [PMID: 28423012 DOI: 10.1371/journal.pone.0176106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
85 Li YT, Huang JR, Peng ML. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. Biomed Res Int 2020;2020:3743962. [PMID: 32724800 DOI: 10.1155/2020/3743962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Kulhankova K, King J, Salgado-Pabón W. Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression. Immunol Res 2014;59:182-7. [PMID: 24816557 DOI: 10.1007/s12026-014-8538-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
87 Armstrong LE, Lee EC, Armstrong EM. Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke. J Sports Med (Hindawi Publ Corp) 2018;2018:5724575. [PMID: 29850597 DOI: 10.1155/2018/5724575] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
88 Abenavoli L, Scarpellini E, Rouabhia S, Balsano C, Luzza F. Probiotics in non-alcoholic fatty liver disease: which and when. Annals of Hepatology 2013;12:357-63. [DOI: 10.1016/s1665-2681(19)30997-4] [Cited by in Crossref: 24] [Article Influence: 2.7] [Reference Citation Analysis]
89 Segovia-zafra A, Di Zeo-sánchez DE, López-gómez C, Pérez-valdés Z, García-fuentes E, Andrade RJ, Lucena MI, Villanueva-paz M. Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B 2021;11:3685-726. [DOI: 10.1016/j.apsb.2021.11.013] [Reference Citation Analysis]
90 Thiele M, Wiest R, Gluud LL, Albillos A, Krag A. Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis? Med Hypotheses. 2013;81:871-874. [PMID: 24060485 DOI: 10.1016/j.mehy.2013.08.026] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
91 Mortensen C, Karlsen S, Grønbæk H, Nielsen DT, Frevert S, Clemmesen JO, Møller S, Jensen JS, Bendtsen F. No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion. Liver Int 2013;33:1309-15. [PMID: 23763259 DOI: 10.1111/liv.12205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
92 Tsochatzis EA, Bosch J, Burroughs AK. New therapeutic paradigm for patients with cirrhosis. Hepatology. 2012;56:1983-1992. [PMID: 22729954 DOI: 10.1002/hep.25915] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 9.3] [Reference Citation Analysis]
93 Cai Y, Lu D, Zou Y, Zhou C, Liu H, Tu C, Li F, Liu L, Zhang S. Curcumin Protects Against Intestinal Origin Endotoxemia in Rat Liver Cirrhosis by Targeting PCSK9. J Food Sci 2017;82:772-80. [PMID: 28196290 DOI: 10.1111/1750-3841.13647] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
94 Wright G, Swain M, Annane D, Saliba F, Samuel D, Arroyo V, DeMorrow S, Witt A. Neuroinflammation in liver disease: sessional talks from ISHEN. Metab Brain Dis 2016;31:1339-54. [PMID: 27726053 DOI: 10.1007/s11011-016-9918-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
95 Yilmaz Y. Review article: fructose in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35:1135-1144. [PMID: 22469071 DOI: 10.1111/j.1365-2036.2012.05080.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
96 Anty R, Lemoine M. Liver fibrogenesis and metabolic factors. Clin Res Hepatol Gastroenterol. 2011;35 Suppl 1:S10-S20. [PMID: 21742296 DOI: 10.1016/s2210-7401(11)70003-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
97 Akiba Y, Maruta K, Takajo T, Narimatsu K, Said H, Kato I, Kuwahara A, Kaunitz JD. Lipopolysaccharides transport during fat absorption in rodent small intestine. Am J Physiol Gastrointest Liver Physiol 2020;318:G1070-87. [PMID: 32390462 DOI: 10.1152/ajpgi.00079.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
98 Taprantzi D, Zisimopoulos D, Thomopoulos KC, Spiliopoulou I, Georgiou CD, Tsiaoussis G, Triantos C, Gogos CA, Labropoulou-Karatza C, Assimakopoulos SF. Propranolol reduces systemic oxidative stress and endotoxemia in cirrhotic patients with esophageal varices. Ann Gastroenterol 2018;31:224-30. [PMID: 29507470 DOI: 10.20524/aog.2017.0222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Jain L, Sharma BC, Sharma P, Srivastava S, Agrawal A, Sarin SK. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis. 2012;44:1027-1031. [PMID: 22883217 DOI: 10.1016/j.dld.2012.07.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
100 Fukui H. How leaky gut and endotoxemia induce bacterial infection in cirrhosis and gastrointestinal hemorrhage? J Gastroenterol Hepatol. 2011;26:423-425. [PMID: 21332539 DOI: 10.1111/j.1440-1746.2011.06668.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
101 Balakrishnan A, DasSarma P, Bhattacharjee O, Kim JM, DasSarma S, Chakravortty D. Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock. Sci Rep 2016;6:33679. [PMID: 27646594 DOI: 10.1038/srep33679] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
102 Gao LN, Yan K, Cui YL, Fan GW, Wang YF. Protective effect of Salvia miltiorrhiza and Carthamus tinctorius extract against lipopolysaccharide-induced liver injury. World J Gastroenterol 2015; 21(30): 9079-9092 [PMID: 26290634 DOI: 10.3748/wjg.v21.i30.9079] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
103 Zheng Z, Wang B. The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration. Front Immunol 2021;12:775526. [PMID: 34956204 DOI: 10.3389/fimmu.2021.775526] [Reference Citation Analysis]
104 McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev. 2011;CD008716. [PMID: 22071855 DOI: 10.1002/14651858.cd008716.pub2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.1] [Reference Citation Analysis]
105 Kröger I, Humer E, Neubauer V, Reisinger N, Zebeli Q. Feeding Diets Moderate in Physically Effective Fibre Alters Eating and Feed Sorting Patterns without Improving Ruminal pH, but Impaired Liver Health in Dairy Cows. Animals (Basel) 2019;9:E128. [PMID: 30934873 DOI: 10.3390/ani9040128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
106 Xu R, Xiu L, Zhang Y, Du R, Wang X. Probiotic and hepatoprotective activity of lactobacillus isolated from Mongolian camel milk products. Beneficial Microbes 2019;10:699-710. [DOI: 10.3920/bm2018.0131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
107 Gan Z, Wei W, Li Y, Wu J, Zhao Y, Zhang L, Wang T, Zhong X. Curcumin and Resveratrol Regulate Intestinal Bacteria and Alleviate Intestinal Inflammation in Weaned Piglets. Molecules 2019;24:E1220. [PMID: 30925757 DOI: 10.3390/molecules24071220] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
108 Dongiovanni P, Meroni M, Longo M, Fargion S, Fracanzani AL. Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC. Biomedicines 2021;9:1524. [PMID: 34829753 DOI: 10.3390/biomedicines9111524] [Reference Citation Analysis]
109 Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 2017;14:527-39. [PMID: 28676707 DOI: 10.1038/nrgastro.2017.72] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 35.2] [Reference Citation Analysis]
110 Raparelli V, Basili S, Carnevale R, Napoleone L, Del Ben M, Nocella C, Bartimoccia S, Lucidi C, Talerico G, Riggio O, Violi F. Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology 2017;65:571-81. [PMID: 27641757 DOI: 10.1002/hep.28853] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 10.0] [Reference Citation Analysis]
111 Cheung A, Flamm S. Hepatobiliary Complications in Critically Ill Patients. Clin Liver Dis 2019;23:221-32. [PMID: 30947873 DOI: 10.1016/j.cld.2018.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
112 Violi F, Corazza GR, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S; PRO-LIVER Collaborators. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. Intern Emerg Med. 2016;11:1059-1066. [PMID: 27026379 DOI: 10.1007/s11739-016-1416-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 8.2] [Reference Citation Analysis]
113 Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in Glutathione Content in Liver Diseases: An Update. Antioxidants (Basel) 2021;10:364. [PMID: 33670839 DOI: 10.3390/antiox10030364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
114 Ommati MM, Farshad O, Mousavi K, Jamshidzadeh A, Azmoon M, Heidari S, Azarpira N, Niknahad H, Heidari R. Betaine supplementation mitigates intestinal damage and decreases serum bacterial endotoxin in cirrhotic rats. PharmaNutrition 2020;12:100179. [DOI: 10.1016/j.phanu.2020.100179] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
115 Shetab Boushehri MA, Lamprecht A. Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto. Therapeutic Delivery 2019;10:165-87. [DOI: 10.4155/tde-2018-0076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
116 Mercer DF. Fish oil emulsions in the management of intestinal failure-associated liver disease. J Clin Gastroenterol 2012;46:823-7. [PMID: 23060217 DOI: 10.1097/MCG.0b013e318261836d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
117 Jiang MP, Xu C, Guo YW, Luo QJ, Li L, Liu HL, Jiang J, Chen HX, Wei XQ. β-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4/NF-κB signaling pathway-mediated inflammation in mice. World J Gastroenterol 2018; 24(2): 216-225 [PMID: 29375207 DOI: 10.3748/wjg.v24.i2.216] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
118 Assimakopoulos SF, Gogos C, Labropoulou-karatza C. Could antioxidants be the “magic pill” for cirrhosis-related complications? A pathophysiological appraisal. Medical Hypotheses 2011;77:419-23. [DOI: 10.1016/j.mehy.2011.05.034] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
119 Liang FF, Liu CP, Li LX, Xue MM, Xie F, Guo Y, Bai L. Activated effects of parathyroid hormone-related protein on human hepatic stellate cells. PLoS One 2013;8:e76517. [PMID: 24116114 DOI: 10.1371/journal.pone.0076517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
120 Zhang L, Wu Y, Chen T, Ren C, Li X, Liu G. Relationship between intestinal microbial dysbiosis and primary liver cancer. Hepatobiliary & Pancreatic Diseases International 2019;18:149-57. [DOI: 10.1016/j.hbpd.2019.01.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
121 Huang W, Ding H, Chen LY, Ni L, Ruan YF, Zou XX, Ye M, Zou SQ. Protective Effect of the Total Triterpenes of Euscaphis konishii Hayata Pericarp on Bacillus Calmette-Guérin Plus Lipopolysaccharide-Induced Liver Injury. Evid Based Complement Alternat Med 2019;2019:1806021. [PMID: 31080480 DOI: 10.1155/2019/1806021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
122 Yao M, Wang L, Wang J, Liu Y, Liu S, Zhao J, Lu F, Tu W. Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis. Disease Markers 2022;2022:1-7. [DOI: 10.1155/2022/4253566] [Reference Citation Analysis]
123 Ding R, Han J, Zhao D, Hu Z, Ma X. Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function. Int Immunopharmacol 2016;40:125-30. [PMID: 27588912 DOI: 10.1016/j.intimp.2016.08.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
124 Trebicka J, Krag A, Gansweid S, Appenrodt B, Schiedermaier P, Sauerbruch T, Spengler U. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol. 2011;23:1218-1225. [PMID: 21971377 DOI: 10.1097/meg.0b013e32834a75dc] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 4.9] [Reference Citation Analysis]
125 He Y, Ma J, Fan X, Ding L, Ding X, Zhang Q, Lin G. The key role of gut–liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity. Acta Pharmaceutica Sinica B 2021;11:3820-35. [DOI: 10.1016/j.apsb.2021.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Ning C, Gao X, Wang C, Huo X, Liu Z, Sun H, Yang X, Sun P, Ma X, Meng Q, Liu K. Protective effects of ginsenoside Rg1 against lipopolysaccharide/ d -galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway. International Immunopharmacology 2018;61:266-76. [DOI: 10.1016/j.intimp.2018.06.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
127 Abenavoli L, Milic N, De Lorenzo A, Luzza F. A pathogenetic link between non-alcoholic fatty liver disease and celiac disease. Endocrine. 2013;43:65-67. [PMID: 22740094 DOI: 10.1007/s12020-012-9731-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
128 Xie J, Wu X, Zhou Q, Yang Y, Tian Y, Huang C, Meng X, Li J. PICK1 confers anti-inflammatory effects in acute liver injury via suppressing M1 macrophage polarization. Biochimie 2016;127:121-32. [PMID: 27157267 DOI: 10.1016/j.biochi.2016.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
129 Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, Zhou J, Ni S, Liu L, Pons N, Batto JM, Kennedy SP, Leonard P, Yuan C, Ding W, Chen Y, Hu X, Zheng B, Qian G, Xu W, Ehrlich SD, Zheng S, Li L. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513:59-64. [PMID: 25079328 DOI: 10.1038/nature13568] [Cited by in Crossref: 980] [Cited by in F6Publishing: 893] [Article Influence: 122.5] [Reference Citation Analysis]
130 Jin P, Chen Y, Lv L, Yang J, Lu H, Li L. Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-α Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism. PLoS One 2015;10:e0126520. [PMID: 25978374 DOI: 10.1371/journal.pone.0126520] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
131 Gao B, Bertola A. Natural killer cells take two tolls to destruct bile ducts. Hepatology 2011;53:1076-9. [PMID: 21384404 DOI: 10.1002/hep.24275] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
132 Luo L, Zhou Z, Xue J, Wang Y, Zhang J, Cai X, Liu Y, Yang F. Bletilla striata polysaccharide has a protective effect on intestinal epithelial barrier disruption in TAA-induced cirrhotic rats. Exp Ther Med 2018;16:1715-22. [PMID: 30186392 DOI: 10.3892/etm.2018.6430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
133 Zhong Z, Lemasters JJ. A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease. Alcohol Clin Exp Res 2018;42:2072-89. [PMID: 30132924 DOI: 10.1111/acer.13877] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
134 Romeiro FG, da Silva Yamashiro F, Américo MF, Corá LA, Silva GF, Miranda JR, Caramori CA. Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study. BMC Gastroenterol. 2013;13:13. [PMID: 23324408 DOI: 10.1186/1471-230x-13-13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
135 Madsen BS, Havelund T, Krag A. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers. Adv Ther 2013;30:659-70. [PMID: 23881723 DOI: 10.1007/s12325-013-0044-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
136 Dong S, Qian W, Liu T, Liu H, Du J, Zhao H, Gao F, Cai J. Repeated 0.2-Gy γ-Ray Irradiation Attenuates the Inflammatory Process and Endotoxin Damage Induced by Lipopolysaccharides. Dose Response 2019;17:1559325819836355. [PMID: 31258453 DOI: 10.1177/1559325819836355] [Reference Citation Analysis]
137 Zhang P, Zheng L, Duan Y, Gao Y, Gao H, Mao D, Luo Y. Gut microbiota exaggerates triclosan-induced liver injury via gut-liver axis. J Hazard Mater 2021;421:126707. [PMID: 34315018 DOI: 10.1016/j.jhazmat.2021.126707] [Reference Citation Analysis]
138 Takaya H, Kawaratani H, Kubo T, Seki K, Sawada Y, Kaji K, Okura Y, Takeda K, Kitade M, Moriya K, Namisaki T, Mitoro A, Matsumoto M, Fukui H, Yoshiji H. Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis. Hepatol Res 2018;48:E52-60. [PMID: 28628948 DOI: 10.1111/hepr.12926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
139 Lv H, Qi Z, Wang S, Feng H, Deng X, Ci X. Asiatic Acid Exhibits Anti-inflammatory and Antioxidant Activities against Lipopolysaccharide and d-Galactosamine-Induced Fulminant Hepatic Failure. Front Immunol 2017;8:785. [PMID: 28736552 DOI: 10.3389/fimmu.2017.00785] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 7.0] [Reference Citation Analysis]
140 Zhang JJ, Fan YC, Zhao ZH, Yang Y, Dou CY, Gao S, Wang K. Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment. Cell Mol Immunol 2014;11:396-404. [PMID: 24727541 DOI: 10.1038/cmi.2014.23] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
141 Zhao L, Chen F, Zhang Y, Yue L, Guo H, Ye G, Shi F, Lv C, Jing B, Tang H, Yin Z, Fu H, Lin J, Li Y, Wang X. Involvement of P450s and nuclear receptors in the hepatoprotective effect of quercetin on liver injury by bacterial lipopolysaccharide. Immunopharmacol Immunotoxicol 2020;42:211-20. [PMID: 32253952 DOI: 10.1080/08923973.2020.1742154] [Reference Citation Analysis]
142 Wang M, Ma YP, Li YW, Wei J, Zhang JH, He T, Chen SM. Oligomeric proanthocyanidins from grape seeds protect against alcohol-induced liver injury and cerebral dysfunction in rats. Shijie Huaren Xiaohua Zazhi 2013; 21(16): 1480-1486 [DOI: 10.11569/wcjd.v21.i16.1480] [Reference Citation Analysis]
143 Fletcher NF, Sutaria R, Jo J, Barnes A, Blahova M, Meredith LW, Cosset FL, Curbishley SM, Adams DH, Bertoletti A. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology. 2014;59:1320-1330. [PMID: 24259385 DOI: 10.1002/hep.26911] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
144 Massey VL, Beier JI, Ritzenthaler JD, Roman J, Arteel GE. Potential Role of the Gut/Liver/Lung Axis in Alcohol-Induced Tissue Pathology. Biomolecules 2015;5:2477-503. [PMID: 26437442 DOI: 10.3390/biom5042477] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
145 Liu Y, Li F, Zhang L, Wu J, Wang Y, Yu H. Taurine alleviates lipopolysaccharide‑induced liver injury by anti‑inflammation and antioxidants in rats. Mol Med Rep 2017;16:6512-7. [PMID: 28901400 DOI: 10.3892/mmr.2017.7414] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
146 Jayakumar T, Hou SM, Chang CC, Fong TH, Hsia CW, Chen YJ, Huang WC, Saravanabhavan P, Manubolu M, Sheu JR, Hsia CH. Columbianadin Dampens In Vitro Inflammatory Actions and Inhibits Liver Injury via Inhibition of NF-κB/MAPKs: Impacts on OH Radicals and HO-1 Expression. Antioxidants (Basel) 2021;10:553. [PMID: 33918237 DOI: 10.3390/antiox10040553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Wang L, Wang X, Kong L, Wang S, Huang K, Wu J, Wang C, Sun H, Liu K, Meng Q. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response. Int Immunopharmacol 2021;100:108159. [PMID: 34555641 DOI: 10.1016/j.intimp.2021.108159] [Reference Citation Analysis]
148 Roussel E, Brasse-Lagnel C, Tuech JJ, Montialoux H, Papet E, Tortajada P, Bekri S, Schwarz L. Influence of Probiotics Administration Before Liver Resection in Patients with Liver Disease: A Randomized Controlled Trial. World J Surg 2021. [PMID: 34837121 DOI: 10.1007/s00268-021-06388-7] [Reference Citation Analysis]
149 Wosiewicz P, Żorniak M, Hartleb M, Barański K, Hartleb M, Onyszczuk M, Pilch-Kowalczyk J, Kyrcz-Krzemień S. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability. Clin Res Hepatol Gastroenterol 2016;40:722-9. [PMID: 27160816 DOI: 10.1016/j.clinre.2016.03.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
150 Assimakopoulos SF, Tsamandas AC, Tsiaoussis GI, Karatza E, Triantos C, Vagianos CE, Spiliopoulou I, Kaltezioti V, Charonis A, Nikolopoulou VN, Scopa CD, Thomopoulos KC. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. Eur J Clin Invest. 2012;42:439-446. [PMID: 22023490 DOI: 10.1111/j.1365-2362.2011.02609.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
151 Chen EQ, Zeng F, Zhou LY, Tang H. Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure. World J Gastroenterol 2015; 21(42): 11964-11973 [PMID: 26576085 DOI: 10.3748/wjg.v21.i42.11964] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
152 Patel VC, White H, Støy S, Bajaj JS, Shawcross DL. Clinical science workshop: targeting the gut-liver-brain axis. Metab Brain Dis 2016;31:1327-37. [PMID: 26446022 DOI: 10.1007/s11011-015-9743-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
153 Zhang F, Jin H, Wu L, Shao J, Wu X, Lu Y, Zheng S. Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes. Biomedicine & Pharmacotherapy 2016;78:204-9. [DOI: 10.1016/j.biopha.2016.01.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
154 Cao S, Zhu C, Feng J, Zhu L, Yin J, Xu Y, Yang H, Huang Y, Zhang Q. Helicobacter hepaticus infection induces chronic hepatitis and fibrosis in male BALB/c mice via the activation of NF-κB, Stat3, and MAPK signaling pathways. Helicobacter 2020;25:e12677. [PMID: 31881556 DOI: 10.1111/hel.12677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
155 Iracheta-Vellve A, Petrasek J, Satishchandran A, Gyongyosi B, Saha B, Kodys K, Fitzgerald KA, Kurt-Jones EA, Szabo G. Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice. J Hepatol 2015;63:1147-55. [PMID: 26100496 DOI: 10.1016/j.jhep.2015.06.013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 10.1] [Reference Citation Analysis]